GSK
Head, Oncology Clinical Development - ADCs
$242K–$404K
USA - Pennsylvania - Upper Providence +4 · Hybrid (Remote & On-site) · Full-time · Posted Oct 19, 2026
- Location
- USA - Pennsylvania - Upper Providence
USA - Massachusetts - Waltham
UK - Hertfordshire - Stevenage
Switzerland - Zug
UK – London – New Oxford Street - Education
- Medical degree (MD, MBBS, MBChB or international equivalent); or international equivalent.
About the job
Leads end-to-end clinical development strategy and execution for an oncology antibody-drug-conjugate asset across tumor types, from early development through regulatory approval and launch readiness.
What you'll do
- Set and deliver asset clinical development strategy, including registrational trials, combinations, and lifecycle planning.
- Oversee program progress, risks, governance, and regulatory readiness; represent the asset at senior forums.
- Lead global cross-functional partnerships and promote scientific excellence, collaboration, and continuous improvement.
What they ask for
- Medical degree (MD, MBBS, MBChB or international equivalent).
- Board certification/eligibility or registration in a primary or medical specialty.
- Oncology drug development experience in the pharmaceutical industry, including leadership of early- and focused late-phase programs from first-in-human through registrational studies and launch readiness.
- Experience leading Antibody Drug Conjugate or other targeted oncology programs, owning asset- or portfolio-level strategy and execution, engaging global health authorities, and leading global cross-functional teams.
Nice to have
- Board certification/eligibility or registration in medical oncology or hematology/oncology.
- Experience in translational research, governance leadership, or innovative development approaches such as AI/ML, real-world evidence, and novel trial design.
Pay
$242,250 to $403,750 USD annual base salary
Tools
AI/ML, advanced analytics, real-world evidence, novel trial design
AI focus
Evaluate and enable AI/ML where it adds scientific, operational, or decision-making value to clinical development.
Model-written summary · the original posting is authoritative